Imvaq Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Imvaq Therapeutics's estimated annual revenue is currently $310k per year.
- Imvaq Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Imvaq Therapeutics has 4 Employees.
- Imvaq Therapeutics grew their employee count by 0% last year.
Imvaq Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Manufacturing | Reveal Email/Phone |
Imvaq Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Imvaq Therapeutics?
Imvaq is an innovative biotechnology company developing novel immuno-oncologics to treat metastatic cancer. Based on the research of Imvaq's distinguished scientific founders at Memorial Sloan Kettering Cancer Center, one of the leading clinical and R&D cancer hospitals in the world, we are focused on creating therapeutic products that synergize with a patient's own immune system to eradicate the cancer, locally and abscopally.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$310k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 4 | -33% | N/A |
#2 | $0.3M | 4 | -20% | N/A |
#3 | $0.5M | 4 | 0% | N/A |
#4 | $0.3M | 4 | 0% | N/A |
#5 | $0.3M | 4 | -33% | N/A |